Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Polycystic Ovary Syndrome 5Neoplasms 2Stroke 1Psoriasis 1Ovarian Neoplasms 1Myocardial Infarction 1Infertility 1Folic Acid Deficiency 1Cardiovascular Diseases 1Breast Neoplasms 1Arthritis, Rheumatoid 1Anovulation 1Anemia 1

Interventions

Letrozole 20Docetaxel 16Cyclophosphamide 13Zoledronic Acid 12exemestane 11Trastuzumab 11Anastrozole 11Paclitaxel 10Tamoxifen 9Capecitabine 9Fulvestrant 8Epirubicin 8pegfilgrastim 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Saline Solution 6palbociclib 5Sodium Chloride 5Dexmedetomidine 5Carboplatin 5Bupivacaine 5Bevacizumab 5ribociclib 4pegylated granulocyte colony-stimulating factor 4eribulin 4Tranexamic Acid 4Standard of Care 4Pamidronate 4Filgrastim 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Breast Neoplasms × Folic Acid × Clear all
NCT04024254 2026-03-04

A Study of Serum Folate Levels in Patients Treated With Olaparib

Rush University Medical Center

Phase 4 Completed
10 enrolled 14 charts
BreastGynecologic

Breast Neoplasms, Folic Acid Deficiency, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡